These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34289425)

  • 1. Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Rabinowitz J; Rabinowitz AA
    Psychiatry Res; 2021 Sep; 303():114114. PubMed ID: 34289425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outlier-response pattern checks to improve measurement with the Montgomery-Asberg depression rating scale (MADRS).
    Rabinowitz J; Rabinowitz AA
    J Affect Disord; 2022 Feb; 299():444-448. PubMed ID: 34952105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D).
    Rabinowitz J; Williams JBW; Anderson A; Fu DJ; Hefting N; Kadriu B; Kott A; Mahableshwarkar A; Sedway J; Williamson D; Yavorsky C; Schooler NR
    J Affect Disord; 2022 Apr; 302():273-279. PubMed ID: 35101520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A).
    Rabinowitz J; Williams JBW; Hefting N; Anderson A; Brown B; Fu DJ; Kadriu B; Kott A; Mahableshwarkar A; Sedway J; Williamson D; Yavorsky C; Schooler NR
    J Affect Disord; 2023 Mar; 325():429-436. PubMed ID: 36638966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistency checks to improve measurement with the Personal and Social Performance Scale (PSP).
    Rabinowitz J; Opler M; Rabinowitz AA; Negash S; Anderson A; Fu DJ; Williamson D; Kott A; Davis LL; Schooler NR
    Schizophr Res; 2021 Feb; 228():529-533. PubMed ID: 33248884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Rabinowitz J; Schooler NR; Anderson A; Ayearst L; Daniel D; Davidson M; Khan A; Kinon B; Menard F; Opler L; Opler M; Severe JB; Williamson D; Yavorsky C; Zhao J;
    Schizophr Res; 2017 Dec; 190():74-76. PubMed ID: 28285023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency checks to improve measurement with the Young Mania Rating Scale (YMRS).
    Rabinowitz J; Young RC; Yavorsky C; Williams JBW; Sedway J; Marino P; Matteo C; Mahableshwarkar A; Kott A; Hefting N; Engler J; Brady C
    J Affect Disord; 2024 Jan; 345():24-31. PubMed ID: 37865349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency checks to improve measurement with the Montgomery-Asberg Depression Rating Scale (MADRS).
    Rabinowitz J; Schooler NR; Brown B; Dalsgaard M; Engelhardt N; Friedberger G; Kinon BJ; Lee D; Ockun F; Mahableshwarkar A; Tsai J; Williams JBW; Sauder C; Yavorsky C;
    J Affect Disord; 2019 Sep; 256():143-147. PubMed ID: 31176186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Item response analysis of the Positive and Negative Syndrome Scale.
    Santor DA; Ascher-Svanum H; Lindenmayer JP; Obenchain RL
    BMC Psychiatry; 2007 Nov; 7():66. PubMed ID: 18005449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS).
    Khan A; Yavorsky WC; Liechti S; DiClemente G; Rothman B; Opler M; DeFries A; Jovic S
    J Clin Psychopharmacol; 2013 Feb; 33(1):109-17. PubMed ID: 23277234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia.
    Kozielska M; Pilla Reddy V; Johnson M; de Ridder F; Vermeulen A; Liu J; Groothuis GM; Danhof M; Proost JH
    Schizophr Res; 2013 May; 146(1-3):53-8. PubMed ID: 23434198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS score.
    Pilla Reddy V; Kozielska M; Suleiman AA; Johnson M; Vermeulen A; Liu J; de Greef R; Groothuis GM; Danhof M; Proost JH
    Schizophr Res; 2013 May; 146(1-3):153-61. PubMed ID: 23473811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.
    Suzuki T; Remington G; Mulsant BH; Uchida H; Rajji TK; Graff-Guerrero A; Mimura M; Mamo DC
    Psychiatry Res; 2012 May; 197(1-2):1-6. PubMed ID: 22429484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents.
    Glick ID; Lemmens P; Vester-Blokland E
    Int Clin Psychopharmacol; 2001 Sep; 16(5):265-74. PubMed ID: 11552769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
    Lin CH; Lin HS; Lin SC; Kuo CC; Wang FC; Huang YH
    Acta Psychiatr Scand; 2018 Feb; 137(2):98-108. PubMed ID: 29280500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the PANSS be rescaled?
    Obermeier M; Mayr A; Schennach-Wolff R; Seemüller F; Möller HJ; Riedel M
    Schizophr Bull; 2010 May; 36(3):455-60. PubMed ID: 19889950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP; Brown E; Baker RW; Schuh LM; Shao L; Tohen M; Ahmed S; Stauffer VL
    Schizophr Res; 2004 Jun; 68(2-3):331-7. PubMed ID: 15099614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.
    Szegedi A; Verweij P; van Duijnhoven W; Mackle M; Cazorla P; Fennema H
    J Clin Psychiatry; 2012 Dec; 73(12):1533-40. PubMed ID: 23290326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.